TALKING POINTS | HEALTHCARE & LIFE SCIENCE 23/01/2018

In today’s talking points, Chinese investors back Aussie baby product review site,Chinese scientists produce genetically-enhanced human vascular cells, and Mega-popular Chinese Reality Show has a date in Rockingham.   Chinese Investors Back Aussie Baby Product Review Site Australian baby product review website, Tell Me Baby, will expand into China this year, having already raised over 700,000 …

Healthcare & Life Science Talking Points | 11 January 2019

In today’s talking points, Beijing municipal government moved to Tongzhou, China’s birth number in 2018 may drop to the lowest since 2000, Chinese hospital deploys AI to detect blind-causing diseases, and an increased number of Chinese firms attend the world’s biggest healthcare meet.   Beijing Municipal Government Moved to Tongzhou Beijing Municipal People’s government officially …

Healthcare & Life Science Talking Points | 17 December 2018

In today’s talking points, API proposes AUS$727 Million to Buy Sigma Healthcare, Researchers finds a new blood test that could save millions from blindness, Chinese resources and State Path Capital increasingly looking to work with Australian healthcare and China’s healthcare information technology momentum: an insider’s look. API Proposes AUS$727 Million to Buy Sigma Healthcare  Australian …

Healthcare & Life Science Talking Points | 4 December 2018

In today’s talking points, US and China reach an agreement regarding the classification of synthetic oploids, low-protein, high carbohydrate diet best for longevity, healthy brain ageing, Industry leaders Jianke.com and Pfizer to enter into strategic partnership, and Extreme temperatures are more detrimental to our mental health than we thought.    US and China reach an …

Healthcare & Life Science Talking Points | 27/11/18

  In today’s talking points, Australia pushes for mandatory health insurance for prospective travellers, The George Institute Re-explores Health Communication – a critical area for sustainable healthcare reforms, and Australia seeks aid from the US to help reduce diabetes in China.   Australia pushes for mandatory health insurance for prospective travellers There has been a …

Healthcare & Life Science Talking Points | 18/09/18

In today’s talking points Australia aged-care inquiry wipes $318 million off health stocks, second carcinogen found in common Chinese produced heart drug and Australian Senate inquiry told that 900,000 Australians have opted out of My Health Record database.   Australia Aged-Care Inquiry Wipes $318 Million Off Health Stocks After Australia’s new Prime Minister Scott Morrison …

Healthcare & Life Science Talking Points | 30/08/18

In today’s talking points China health reforms help global pharma groups despite price cuts, robot academy to train surgeons in Australia, China introduces smart technologies to promote elderly care services and BGI, Xing Tech to advance diagnostic technologies.   China health reforms help global pharma groups despite price cuts Beijing has forced the world’s top pharmaceutical companies …

Healthcare & Life Science Talking Points | 16/08/18

In today’s talking points Fewer Australians are dying from hepatitis C but thousands are still missing out on treatment,The true cost of staying healthy in Australia revealed, FDA recalls are a reminder that China controls much of world’s drug supply, Centrelink new robodebt trial bypasses previous safeguard for mentally ill   Fewer Australians are dying from hepatitis C, …

Healthcare & Life Science Talking Points | 07/08/18

In today’s Talking Points Ningxia to build China’s first Internet Plus Healthcare demo zone, Private health sector most vulnerable to data breaches – report, Queensland hospitals to ban junk food and sugary drinks, China to subsidise more cancer drugs.   Ningxia to build China’s first Internet Plus Healthcare demo zone The regional government of northwest …

Healthcare & Life Science Talking Points | 18/07/18

In today’s Talking Points: China’s new Alzheimer’s drug completes phase 3 clinical trial, Greg Hunt’s private health insurance overhaul accused of inflating costs,    China’s new Alzheimer’s drug completes phase 3 clinical trial GV-971 was developed by Ocean University of China, Shanghai Institute of Materia Medica under Chinese Academy of Sciences and Green Valley Pharmaceutical Co., Ltd, …